Nick Cozzarelli, a second-year student at Hackensack Meridian School of Medicine, has been as acutely stung by the COVID-19 era as just about anyone.
Pharmaceutical company Eisai Inc. signed a 332,800-square-foot lease for the entirety of the former Hoffmann-La Roche headquarters building at Prism Capital Partners’ ON3 mixed-use campus in Nutley, New Jersey.
Eisai, an oncology and neurology-focused pharmaceutical company, is the latest firm to call Prism’s On3 campus home.
Savills has represented pharma giant Eisai Inc. in New Jersey’s largest office lease of 2020.
Eisai Inc., a global pharmaceutical company, will be relocating its headquarters to Prism Capital Partners‘ ON3 property, a 116-acre campus on the border of Clifton and Nutley.
Japan-based Eisai Inc., an oncology- and neurology-focused pharmaceutical company, on Tuesday said it is relocating its New Jersey-based headquarters to the ON3 campus in Nutley.
Eisai Inc., an oncology- and neurology-focused pharmaceutical company and the U.S. subsidiary of Eisai Co., Ltd., (based in Tokyo) announced the relocation of its New Jersey-based headquarters to the technologically-advanced and cutting-edge ON3 property in Nutley.
Eisai, an oncology and neurology-focused pharmaceutical company, is the latest firm to call Prism’s On3 campus home.